This study is being done to provide resources for future studies involving autoimmune and rheumatic disorders, such as systemic lupus erythematosus, rheumatoid arthritis, osteoarthritis, Sjogren’s syndrome, vasculitis, and undifferentiated connective tissue diseases. The samples and data collected will be stored and used in the future to learn more about rheumatic and autoimmune disorders. Healthy volunteers are also being recruited.
- 18 years of age or older
If you decide to participate in this study, you will be asked to provide some samples*.
The samples you can provide for this study could be any or all of the following:
• Blood (up to approximately 10 tablespoons)
• Saliva (approximately 2 teaspoons)
• Skin biopsy
• Oral mucosa biopsy
• Medical waste (such as skin or synovial fluid)
*You can choose which types of samples you would like to provide.
The purpose of this study is to test the effects of a new drug called CC-22. Researchers want to find out if it does or does not improve the symptoms of those diagnosed with Systemic Lupus Erythematosus (SLE).
You may be eligible for this study if:
You have been diagnosed with SLE
You have had SLE longer than (or equal to) six (6) months
You have three (3) or more tender joints at the baseline visit
You have skin manifestations of Lupus